IPlato Healthcare
Financials
Estimates*
EUR | 2020 | 2021 | 2022 |
---|---|---|---|
Revenues | 7.7m | 5.1m | 6.6m |
% growth | - | (34 %) | 30 % |
EBITDA | <1m | (2.9m) | (1.1m) |
% EBITDA margin | 9 % | (56 %) | (17 %) |
Profit | <1m | <1m | (4.5m) |
% profit margin | 4 % | 19 % | (68 %) |
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | N/A | - |
£3.5m | Debt | ||
* | N/A | Acquisition | |
* | £1.7m | Grant | |
Total Funding | CAD3.1m |
Related Content
Recent News about IPlato Healthcare
EditiPLATO is a healthcare technology company that specializes in providing customized, actionable insights to improve patient engagement, activity performance, and cost efficiency. Operating primarily in the healthcare sector, iPLATO serves healthcare providers, including clinics and hospitals, by offering a suite of digital tools designed to streamline patient communication and appointment management. The company's core products include the myGP Engagement Hub, which enables large-scale, multi-channel patient communication campaigns, and myGP Messaging, which allows direct communication with patients through various media channels. Additionally, iPLATO offers remote consultation services that help reduce face-to-face appointments by enabling healthcare professionals to make informed triaging decisions remotely. The business model revolves around subscription-based services and bespoke development projects, generating revenue through recurring fees and custom solutions for healthcare providers. iPLATO's solutions seamlessly integrate with existing healthcare systems, making it easier for providers to adopt and benefit from their technology.
Keywords: patient engagement, healthcare efficiency, digital tools, myGP, remote consultation, appointment management, healthcare providers, multi-channel communication, subscription-based, bespoke development.